Literature DB >> 9477984

Nutritional requirements of the corneal epithelium and anterior stroma: clinical findings.

D F Sweeney1, R Z Xie, D J O'Leary, A Vannas, R Odell, K Schindhelm, H Y Cheng, J G Steele, B A Holden.   

Abstract

PURPOSE: To monitor the health of the epithelium and the anterior stroma when porous membranes are implanted into the feline cornea and to determine membrane diffusivity characteristics needed to maintain corneal integrity.
METHODS: Filtration membranes in a range of effective pore sizes of less than 15 nm (groups 1 and 2, n = 11), 25 nm (group 3, n = 8), 50 nm (group 4, n = 16), and 100 nm (group 5, n = 15) were implanted into an interlamellar corneal pocket of the stroma. The implanted membranes ranged in thickness from 6 nm to 15 nm and were between 8 mm and 12 mm in diameter. Animals were monitored for clinical signs of intolerance to the implants.
RESULTS: At 1 month, thinning and ulceration had occurred in the epithelium and the anterior stroma of all animals in groups 1 and 2; epithelial changes, anterior stromal thinning, and ulceration had developed in 75% of animals of group 3; 50% of animals showed vascularization and only 7% showed epithelial degeneration in group 4; and local anterior stromal thinning was observed in 7% of animals in group 5, indicating clinical acceptance of the implanted membrane. In the long term (greater than 50 days), 30% and 73% of the group 4 and 5 corneas, respectively, were clinically quiet. Analysis of the failure times indicated an inverse relation between failure rate and pore size: less than 15 nm > 25 nm > 50 nm > 100 nm. The difference between the 100-nm and 50-nm membranes was significant (P = 0.03).
CONCLUSIONS: A corneal implant must have a porosity greater than that provided by 50-nm membranes. The 100-nm membranes used in this study establish the porosity needed to satisfy the nutritional requirements of the cornea.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9477984

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Cross-linking with ultraviolet-a and riboflavin reduces corneal permeability.

Authors:  Jay M Stewart; On-Tat Lee; Fergus F Wong; David S Schultz; Ricardo Lamy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

Review 2.  Development of hydrogel-based keratoprostheses: a materials perspective.

Authors:  David Myung; Pierre-Emile Duhamel; Jennifer R Cochran; Jaan Noolandi; Christopher N Ta; Curtis W Frank
Journal:  Biotechnol Prog       Date:  2008-04-19

Review 3.  Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.

Authors:  Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

4.  Effects of gamma radiation sterilization on the structural and biological properties of decellularized corneal xenografts.

Authors:  Mohammad Mirazul Islam; Roholah Sharifi; Shamina Mamodaly; Rakibul Islam; Daniel Nahra; Dina B Abusamra; Pui Chuen Hui; Yashar Adibnia; Mehdi Goulamaly; Eleftherios I Paschalis; Andrea Cruzat; Jing Kong; Per H Nilsson; Pablo Argüeso; Tom Eirik Mollnes; James Chodosh; Claes H Dohlman; Miguel Gonzalez-Andrades
Journal:  Acta Biomater       Date:  2019-07-05       Impact factor: 8.947

5.  Collagen Film with Bionic Layered Structure and High Light Transmittance for Personalized Corneal Repair Fabricated by Controlled Solvent Evaporation Technique.

Authors:  Peihong Ji; Chuanlei Zhang; Yanhui Kong; Huiyu Liu; Jia Guo; Longsheng Shi; Hui Yang; Zhongwei Gu; Yang Liu
Journal:  J Funct Biomater       Date:  2022-05-02

6.  Corneal epithelialisation on surface-modified hydrogel implants: artificial cornea.

Authors:  Aihua Ma; Bojun Zhao; Adam J Bentley; Arun Brahma; Sheila MacNeil; Francis L Martin; Stephen Rimmer; Nigel J Fullwood
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.